梅花生物
(600873)
| 流通市值：286.13亿 | | | 总市值：286.13亿 |
| 流通股本：28.53亿 | | | 总股本：28.53亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,635,044,488.5 | 3,690,406,128.39 | 4,618,039,330.1 | 4,969,794,482.39 |
| 衍生金融资产 | 1,474,430 | - | 15,000 | 200,000 |
| 应收票据及应收账款 | 751,131,144.42 | 600,749,210.58 | 887,921,184.26 | 770,359,837.67 |
| 其中：应收票据 | 92,702,023.7 | 58,992,839.12 | 121,916,128.57 | 129,231,952.45 |
| 应收账款 | 658,429,120.72 | 541,756,371.46 | 766,005,055.69 | 641,127,885.22 |
| 应收款项融资 | 48,434,635.02 | 39,572,547.46 | 29,312,948.21 | 60,013,169.98 |
| 预付款项 | 102,144,835.83 | 136,686,055.03 | 393,751,276.98 | 252,089,088.23 |
| 其他应收款合计 | 21,437,664.97 | 29,324,086.29 | 107,759,866.93 | 51,384,535.97 |
| 其中:应收利息 | 2,756,250 | 2,362,500 | 1,968,750 | 1,575,000 |
| 存货 | 1,869,967,037 | 2,504,010,073.02 | 3,170,362,210.33 | 2,922,518,782.97 |
| 一年内到期的非流动资产 | - | 9,356,000 | 19,356,000 | 19,356,000 |
| 其他流动资产 | 202,345,542.87 | 159,670,421.21 | 212,560,944.94 | 289,218,469.96 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 8,649,625,914.87 | 8,133,713,790.25 | 9,608,806,563.4 | 9,507,311,168.5 |
| 非流动资产: | | | | |
| 债权投资 | 10,500,000 | 10,500,000 | 10,500,000 | 10,500,000 |
| 长期应收款 | 604,363.87 | 370,912.63 | 367,919.83 | 364,927.03 |
| 长期股权投资 | 9,681,134.97 | 17,181,856.65 | 18,348,923.11 | 18,942,230.64 |
| 其他权益工具投资 | 559,649,235 | 477,350,680 | 525,512,575 | 512,691,350 |
| 固定资产 | 10,649,124,994.59 | 10,856,869,380.24 | 11,184,309,271.23 | 11,428,700,356.22 |
| 在建工程 | 1,195,320,655.53 | 752,380,604.36 | 190,495,295.92 | 161,961,713.29 |
| 使用权资产 | 9,612,015.81 | 11,280,014.45 | 11,919,733.85 | 9,633,644.09 |
| 无形资产 | 1,352,736,353.06 | 1,364,510,068.26 | 1,170,883,589.25 | 1,075,943,303.26 |
| 商誉 | 11,788,911.79 | 11,788,911.79 | 11,788,911.79 | 11,788,911.79 |
| 长期待摊费用 | 126,754,587.6 | 117,870,113.46 | 113,093,002.63 | 104,076,824.93 |
| 递延所得税资产 | 82,308,774.82 | 85,794,424.34 | 92,487,464.52 | 106,143,010.15 |
| 其他非流动资产 | 877,163,530.5 | 696,810,676.49 | 495,434,065.78 | 209,122,415.35 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 14,885,244,557.54 | 14,402,707,642.67 | 13,825,140,752.91 | 13,649,868,686.75 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 23,534,870,472.41 | 22,536,421,432.92 | 23,433,947,316.31 | 23,157,179,855.25 |
| 流动负债: | | | | |
| 短期借款 | 2,151,399,649.73 | 2,266,700,664.16 | 2,137,941,502.77 | 1,543,869,058.69 |
| 衍生金融负债 | - | - | - | 250,000 |
| 应付票据及应付账款 | 2,742,093,000.67 | 2,559,658,707.96 | 2,379,685,663.5 | 2,608,628,848.71 |
| 其中：应付票据 | 1,344,044,311.96 | 1,035,586,655.13 | 1,005,113,214.2 | 1,183,031,652.44 |
| 应付账款 | 1,398,048,688.71 | 1,524,072,052.83 | 1,374,572,449.3 | 1,425,597,196.27 |
| 合同负债 | 1,042,732,971.32 | 649,201,399.54 | 633,186,469.08 | 892,931,047.76 |
| 应付职工薪酬 | 306,146,311.41 | 251,568,214.88 | 247,232,495.16 | 322,959,640.35 |
| 应交税费 | 148,670,678.04 | 149,668,118.1 | 175,817,765.85 | 256,472,526.55 |
| 其他应付款合计 | 187,779,277.18 | 275,539,934.53 | 254,483,173.29 | 249,853,910.4 |
| 应付股利 | 405,000 | 70,405,000 | 405,000 | 405,000 |
| 一年内到期的非流动负债 | 590,046,413.91 | 361,009,999.34 | 514,402,181.61 | 535,085,272.76 |
| 其他流动负债 | 100,046,251.51 | 63,602,678 | 99,417,145.7 | 118,688,728.75 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 7,268,914,553.77 | 6,576,949,716.51 | 6,442,166,396.96 | 6,528,739,033.97 |
| 非流动负债: | | | | |
| 长期借款 | 1,077,339,750 | 1,379,308,678.57 | 1,655,887,788.31 | 1,999,963,021.77 |
| 租赁负债 | 2,003,939.56 | 2,938,046.76 | 3,054,815.84 | 2,590,305.92 |
| 长期应付款 | 36,983,005.63 | 36,760,350.9 | 36,537,696.18 | 10,500,000 |
| 预计负债 | 32,178,965.18 | 31,919,768.45 | 31,663,389.07 | 45,888,616.17 |
| 递延收益 | 371,878,831.47 | 362,847,762.46 | 373,817,967.68 | 384,988,414.73 |
| 递延所得税负债 | 27,529,902.79 | 19,107,593.03 | 25,485,988.2 | 21,495,649.02 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,547,914,394.63 | 1,832,882,200.17 | 2,126,447,645.28 | 2,465,426,007.61 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 8,816,828,948.4 | 8,409,831,916.68 | 8,568,614,042.24 | 8,994,165,041.58 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,852,788,750 | 2,852,788,750 | 2,943,426,102 | 2,943,426,102 |
| 资本公积 | 263,154,867.05 | 263,154,867.05 | 1,032,707,760.4 | 1,032,707,760.4 |
| 减:库存股 | - | - | 638,328,051.81 | 576,775,719.27 |
| 其他综合收益 | 45,602,220.8 | -24,351,928.6 | 16,585,689.48 | 5,687,647.5 |
| 专项储备 | 5,328,736.71 | 5,328,736.71 | 5,220,632.05 | 3,952,446.88 |
| 盈余公积 | 1,326,294,444.3 | 1,326,294,444.3 | 1,326,294,444.3 | 1,326,294,444.3 |
| 未分配利润 | 10,224,872,505.15 | 9,703,374,646.78 | 10,179,426,697.65 | 9,427,722,131.86 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 14,718,041,524.01 | 14,126,589,516.24 | 14,865,333,274.07 | 14,163,014,813.67 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 14,718,041,524.01 | 14,126,589,516.24 | 14,865,333,274.07 | 14,163,014,813.67 |
| 负债和股东权益合计 | 23,534,870,472.41 | 22,536,421,432.92 | 23,433,947,316.31 | 23,157,179,855.25 |
| 公告日期 | 2024-10-23 | 2024-07-30 | 2024-04-09 | 2024-03-19 |
| 审计意见(境内) | | | | 标准无保留意见 |